These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 7851581

  • 21. Metachromasia of the endocervical epithelium in women treated with gonadotropin releasing hormone agonist.
    Morimura M, Ishiko O, Honda KI, Sumi T, Kawamura N, Wakasa K, Haba T, Ogita S.
    Int J Mol Med; 2001 Sep; 8(3):319-21. PubMed ID: 11494062
    [Abstract] [Full Text] [Related]

  • 22. Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women.
    Vollenhoven BJ, Shekleton P, McDonald J, Healy DL.
    Fertil Steril; 1990 Dec; 54(6):1032-8. PubMed ID: 2123160
    [Abstract] [Full Text] [Related]

  • 23. Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium.
    Gustavsson I, Englund K, Faxén M, Sjöblom P, Lindblom B, Blanck A.
    Mol Hum Reprod; 2000 Jan; 6(1):55-9. PubMed ID: 10611261
    [Abstract] [Full Text] [Related]

  • 24. Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin.
    Matta WH, Shaw RW, Nye M.
    Br J Obstet Gynaecol; 1989 Feb; 96(2):200-6. PubMed ID: 2495020
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment effects of GnRH agonist on the binding of estrogen and progesterone, and the histological findings of uterine leiomyomas.
    Uemura T, Mori J, Yoshimura Y, Minaguchi H.
    Asia Oceania J Obstet Gynaecol; 1991 Dec; 17(4):315-20. PubMed ID: 1724899
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
    Friedman AJ, Lobel SM, Rein MS, Barbieri RL.
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
    [Abstract] [Full Text] [Related]

  • 31. Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report.
    Maheux R, Guilloteau C, Lemay A, Bastide A, Fazekas AT.
    Fertil Steril; 1984 Oct; 42(4):644-6. PubMed ID: 6436065
    [No Abstract] [Full Text] [Related]

  • 32. [Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations].
    Wu J, Cheng Y.
    Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):603-7. PubMed ID: 8745507
    [Abstract] [Full Text] [Related]

  • 33. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
    Nakamura Y, Yoshimura Y, Yamada H, Ubukata Y, Ando M, Suzuki M.
    Fertil Steril; 1991 May; 55(5):900-5. PubMed ID: 1902420
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Oestrogen and progesterone receptor concentrations in leiomyoma and normal myometrium.
    Sadan O, van Iddekinge B, van Gelderen CJ, Savage N, Becker PJ, van der Walt LA, Robinson M.
    Ann Clin Biochem; 1987 May; 24 ( Pt 3)():263-7. PubMed ID: 3606010
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Uterine leiomyoma and LHRH agonist treatment. A preliminary report.
    Rolland R, Franssen AM, Willemsen WN, Corbey RS.
    Prog Clin Biol Res; 1986 May; 225():313-20. PubMed ID: 3097670
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.
    Mozzachio K, Moore AB, Kissling GE, Dixon D.
    Toxicol Pathol; 2016 Apr; 44(3):450-7. PubMed ID: 26692562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.